A genetic variation common in East Asian populations has been linked to cancer drug resistance
04:19 EDT 2 Aug 2012 | Medical Xpress
Tyrosine kinase inhibitors (TKIs) kill cancerous cells by inducing programmed cell death. They are of enormous therapeutic benefit to patients with chronic myeloid leukemia (CML) and certain types of lung cancer, but their effectiveness may vary from..
Original Article: A genetic variation common in East Asian populations has been linked to cancer drug resistance
More From BioPortfolio on "A genetic variation common in East Asian populations has been linked to cancer drug resistance"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
